Pricing Log in Create free account

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) vs Lantern Pharma Inc. (LTRN)

CollPlant Biotechnologies Ltd. Sponsored ADR and Lantern Pharma Inc. are both Biotechnology companies. CollPlant Biotechnologies Ltd. Sponsored ADR and Lantern Pharma Inc. are of similar size ($7.9M and $7.5M). Lantern Pharma Inc. has the higher net margin (0.00% vs −3,934.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Lantern Pharma Inc. leads on 7 and CollPlant Biotechnologies Ltd. Sponsored ADR on 4.

Valuation

Metric CLGN LTRN Biotechnology median
P/E n/m n/m 10.60
P/S 17.47 n/m 9.40
P/B 1.89 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.01 0.66
EV/Sales 25.34 n/m 9.02
Earnings yield (246.04%) (284.21%) (32.88%)
Free cash flow yield (202.39%) (198.83%) (23.13%)

Profitability

Metric CLGN LTRN Biotechnology median
Gross margin (321.70%) 0.00% 68.51%
Operating margin (3,900.94%) 0.00% 0.00%
Net margin (3,934.91%) 0.00% 0.00%
Free cash flow margin (3,522.64%) 0.00% 0.00%
Return on equity (161.98%) (400.91%) (51.96%)
Return on assets (101.59%) (143.36%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLGN LTRN Biotechnology median
Revenue growth (TTM) (86.76%) — 6.76%
EPS growth (last fiscal year) 35.17% 18.65% 29.88%
Revenue growth, 5-year CAGR (17.32%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLGN LTRN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.57 1.96 4.97
Net debt to EBITDA 0.56 0.56 1.01

Dividend

Metric CLGN LTRN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLGN LTRN Biotechnology median
Market cap 7.45m 7.94m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack